Page 4 - Read Online
P. 4

Hepatoma Research
               CONTENTS







               1           Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein
                            level in an Asia-Pacific island cohort
                            Scott T. Nishioka, Miles M. Sato, Linda L. Wong, Maarit Tiirikainen, Sandi A. Kwee
                            Hepatoma Res 2018;4:1  http://dx.doi.org/10.20517/2394-5079.2017.46


               2           Comparison of outcomes between laparoscopic vs. open liver resection for intermediate stage
                            hepatocellular carcinoma
                            Avril David, YoungRok Choi, Ho-Seong Han, Yoo-Seok Yoon, Jai Young Cho
                            Hepatoma Res 2018;4:2  http://dx.doi.org/10.20517/2394-5079.2017.51

               3           Hepatocellular carcinoma in the setting of interferon-free treatment for chronic HCV hepatitis -
                            experience of a single center
                            Elena Laura Iliescu, Adriana Mercan-Stanciu, Letitia Toma, Elena Simona Ioanitescu, Radu Dumitru,
                            Daniel Rusie
                            Hepatoma Res 2018;4:3  http://dx.doi.org/10.20517/2394-5079.2017.48

               4           Qidong hepatitis B virus infection cohort: a 25-year prospective study in high risk area of
                            primary liver cancer
                            Tao-Yang Chen, Geng-Sun Qian, Chun-Sun Fan, Yan Sun, Jin-Bing Wang, Pei-Xin Lu, Xue-Feng Xue,
                            Yan Wu, Qi-Nan Zhang, Yan Jin, Yi-Qian Wu, Yu Gan, Jian-Quan Lu, Thomas W. Kensler, John D.
                            Groopman, Hong Tu
                            Hepatoma Res 2018;4:4  http://dx.doi.org/10.20517/2394-5079.2017.50

               5           Treatment of high-burden hepatocellular carcinoma: an oncologist perspective
                            Landon L. Chan, Stephen L. Chan
                            Hepatoma Res 2018;4:5  http://dx.doi.org/10.20517/2394-5079.2017.49

               6           Direct antiviral therapy for hepatitis C and hepatocellular carcinoma: facing the conundrum
                            Federica Buonfiglioli, Stefano Brillanti
                            Hepatoma Res 2018;4:6  http://dx.doi.org/10.20517/2394-5079.2017.42


               7           Congenital absence of the portal vein complicated by hepatocellular carcinoma in the liver of an
                            adult woman: review of imaging, literature and management
                            Ankit Mehta, Shree R. Venkat, Lorraine Portelance, Lynn G. Feun
                            Hepatoma Res 2018;4:7  http://dx.doi.org/10.20517/2394-5079.2017.35


               8           Prediction of post-progression survival in patients with advanced hepatocellular carcinoma
                            treated with sorafenib by using time-dependent changes in clinical characteristics
                            Yoshiyuki Wada, Yuko Takami, Hajime Matsushima, Masaki Tateishi, Tomoki Ryu, Munehiro
                            Yoshitomi, Hideki Saitsu
                            Hepatoma Res 2018;4:8  http://dx.doi.org/10.20517/2394-5079.2017.39
   1   2   3   4   5   6   7   8   9